# CubeSmart: financial statements, quarterly

CUBE · NYSE · CIK 1298675 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cube.md) · [Financials](/companies/cube/financials.md) · [Filings](/companies/cube/filings.md) · [Insiders](/companies/cube/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cube/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [261](/filings/0001298675-24-000037.md) | [268](/filings/0001298675-24-000046.md) | [265 d](/filings/0001298675-26-000010.md) | [261](/filings/0001298675-25-000020.md) | [266](/filings/0001298675-25-000033.md) | [271](/filings/0001298675-25-000044.md) | [268 d](/filings/0001298675-26-000010.md) | [273](/filings/0001298675-26-000018.md) | [282](/filings/0001298675-25-000033.md) | [285](/filings/0001298675-25-000044.md) | [283 d](/filings/0001298675-26-000010.md) | [282](/filings/0001298675-26-000018.md) |
| Cost of revenue | $m | [74.8](/filings/0001298675-24-000037.md) | [77.5](/filings/0001298675-24-000046.md) | [71.3 d](/filings/0001298675-26-000010.md) | [77.0](/filings/0001298675-25-000020.md) | [83.1](/filings/0001298675-25-000033.md) | [81.9](/filings/0001298675-25-000044.md) | [75.7 d](/filings/0001298675-26-000010.md) | [82.9](/filings/0001298675-26-000018.md) | [89.0](/filings/0001298675-25-000033.md) | [90.8](/filings/0001298675-25-000044.md) | [88.6 d](/filings/0001298675-26-000010.md) | [90.1](/filings/0001298675-26-000018.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [98.3](/filings/0001298675-24-000037.md) | [103](/filings/0001298675-24-000046.md) | [113 d](/filings/0001298675-26-000010.md) | [94.9](/filings/0001298675-25-000020.md) | [94.2](/filings/0001298675-25-000033.md) | [101](/filings/0001298675-25-000044.md) | [102 d](/filings/0001298675-26-000010.md) | [88.7](/filings/0001298675-26-000018.md) | [82.4](/filings/0001298675-25-000033.md) | [82.4](/filings/0001298675-25-000044.md) | [77.7 d](/filings/0001298675-26-000010.md) | [82.8](/filings/0001298675-26-000018.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001298675-24-000037.md) | [0.45](/filings/0001298675-24-000046.md) | not reported | [0.42](/filings/0001298675-25-000020.md) | [0.41](/filings/0001298675-25-000033.md) | [0.44](/filings/0001298675-25-000044.md) | not reported | [0.39](/filings/0001298675-26-000018.md) | [0.36](/filings/0001298675-25-000033.md) | [0.36](/filings/0001298675-25-000044.md) | not reported | [0.36](/filings/0001298675-26-000018.md) |
| Basic EPS | $ per share | [0.43](/filings/0001298675-24-000037.md) | [0.46](/filings/0001298675-24-000046.md) | not reported | [0.42](/filings/0001298675-25-000020.md) | [0.42](/filings/0001298675-25-000033.md) | [0.45](/filings/0001298675-25-000044.md) | not reported | [0.39](/filings/0001298675-26-000018.md) | [0.36](/filings/0001298675-25-000033.md) | [0.36](/filings/0001298675-25-000044.md) | not reported | [0.36](/filings/0001298675-26-000018.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: not reported
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.2](/filings/0001298675-23-000038.md) | [8.0](/filings/0001298675-23-000047.md) | [6.5](/filings/0001298675-25-000011.md) | [5.6](/filings/0001298675-24-000021.md) | [5.7](/filings/0001298675-24-000037.md) | [43.5](/filings/0001298675-24-000046.md) | [71.6](/filings/0001298675-26-000010.md) | [10.8](/filings/0001298675-25-000020.md) | [8.7](/filings/0001298675-25-000033.md) | [108](/filings/0001298675-25-000044.md) | [5.8](/filings/0001298675-26-000018.md) | [7.3](/filings/0001298675-26-000018.md) |
| Total assets | $m | [6,281](/filings/0001298675-23-000038.md) | [6,233](/filings/0001298675-23-000047.md) | [6,225](/filings/0001298675-25-000011.md) | [6,209](/filings/0001298675-24-000021.md) | [6,184](/filings/0001298675-24-000037.md) | [6,192](/filings/0001298675-24-000046.md) | [6,394](/filings/0001298675-26-000010.md) | [6,740](/filings/0001298675-25-000020.md) | [6,709](/filings/0001298675-25-000033.md) | [6,758](/filings/0001298675-25-000044.md) | [6,643](/filings/0001298675-26-000018.md) | [6,598](/filings/0001298675-26-000018.md) |
| Total liabilities | $m | [3,402](/filings/0001298675-23-000038.md) | [3,360](/filings/0001298675-23-000047.md) | [3,344](/filings/0001298675-25-000011.md) | [3,347](/filings/0001298675-24-000021.md) | [3,337](/filings/0001298675-24-000037.md) | [3,320](/filings/0001298675-24-000046.md) | [3,440](/filings/0001298675-26-000010.md) | [3,817](/filings/0001298675-25-000020.md) | [3,820](/filings/0001298675-25-000033.md) | [3,903](/filings/0001298675-25-000044.md) | [3,861](/filings/0001298675-26-000018.md) | [3,893](/filings/0001298675-26-000018.md) |
| Shareholders' equity | $m | [2,801](/filings/0001298675-23-000038.md) | [2,807](/filings/0001298675-23-000047.md) | [2,799](/filings/0001298675-25-000011.md) | [2,782](/filings/0001298675-24-000021.md) | [2,770](/filings/0001298675-24-000037.md) | [2,786](/filings/0001298675-24-000046.md) | [2,872](/filings/0001298675-26-000010.md) | [2,844](/filings/0001298675-25-000020.md) | [2,814](/filings/0001298675-25-000033.md) | [2,782](/filings/0001298675-25-000044.md) | [2,719](/filings/0001298675-26-000018.md) | [2,649](/filings/0001298675-26-000018.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [162 d](/filings/0001298675-24-000037.md) | [170 d](/filings/0001298675-24-000046.md) | [142 d](/filings/0001298675-26-000010.md) | [150](/filings/0001298675-25-000020.md) | [171 d](/filings/0001298675-25-000033.md) | [145 d](/filings/0001298675-25-000044.md) | [165 d](/filings/0001298675-26-000010.md) | [146](/filings/0001298675-26-000018.md) | [157 d](/filings/0001298675-25-000033.md) | [168 d](/filings/0001298675-25-000044.md) | [136 d](/filings/0001298675-26-000010.md) | [149](/filings/0001298675-26-000018.md) |
| Dividends paid | $m | [111 d](/filings/0001298675-24-000037.md) | [111 d](/filings/0001298675-24-000046.md) | [111 d](/filings/0001298675-26-000010.md) | [115](/filings/0001298675-25-000020.md) | [115 d](/filings/0001298675-25-000033.md) | [115 d](/filings/0001298675-25-000044.md) | [116 d](/filings/0001298675-26-000010.md) | [119](/filings/0001298675-26-000018.md) | [119 d](/filings/0001298675-25-000033.md) | [119 d](/filings/0001298675-25-000044.md) | [119 d](/filings/0001298675-26-000010.md) | [121](/filings/0001298675-26-000018.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [33.4](/filings/0001298675-26-000018.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [226](/filings/0001298675-23-000038.md) | [226](/filings/0001298675-23-000047.md) | [226](/filings/0001298675-24-000021.md) | [226](/filings/0001298675-24-000037.md) | [226](/filings/0001298675-24-000046.md) | [227](/filings/0001298675-25-000020.md) | [227](/filings/0001298675-25-000033.md) | [227](/filings/0001298675-25-000044.md) | [229](/filings/0001298675-26-000018.md) | [229](/filings/0001298675-25-000033.md) | [229](/filings/0001298675-25-000044.md) | [228](/filings/0001298675-26-000018.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 226,413,630 at 2026-04-29, from the cover of the [10-Q filed 2026-05-01](/filings/0001298675-26-000018.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.